Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Stenosis | 15 | 2023 | 854 | 3.350 |
Why?
|
Plaque, Atherosclerotic | 14 | 2023 | 1499 | 2.410 |
Why?
|
Leukemia, Myeloid, Acute | 12 | 2022 | 3497 | 2.000 |
Why?
|
Gene Fusion | 9 | 2022 | 371 | 1.790 |
Why?
|
Gene Rearrangement | 8 | 2022 | 1179 | 1.790 |
Why?
|
Oncogene Proteins, Fusion | 11 | 2022 | 1581 | 1.490 |
Why?
|
Tandem Repeat Sequences | 2 | 2022 | 185 | 1.470 |
Why?
|
Carotid Arteries | 13 | 2023 | 952 | 1.380 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2022 | 1515 | 1.350 |
Why?
|
Myelodysplastic Syndromes | 7 | 2022 | 1351 | 1.340 |
Why?
|
Endarterectomy, Carotid | 7 | 2023 | 546 | 1.320 |
Why?
|
Eosinophilia | 4 | 2022 | 531 | 1.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 15 | 2023 | 3585 | 1.220 |
Why?
|
Hematologic Neoplasms | 5 | 2022 | 1820 | 1.210 |
Why?
|
Carotid Artery Diseases | 6 | 2023 | 882 | 1.190 |
Why?
|
Bone Marrow | 7 | 2023 | 2941 | 1.040 |
Why?
|
RNA-Binding Protein EWS | 3 | 2021 | 216 | 0.960 |
Why?
|
Estrogen Receptor alpha | 2 | 2018 | 577 | 0.910 |
Why?
|
In Situ Hybridization, Fluorescence | 11 | 2023 | 2638 | 0.900 |
Why?
|
Plasmacytoma | 1 | 2023 | 182 | 0.840 |
Why?
|
Pancytopenia | 2 | 2020 | 104 | 0.830 |
Why?
|
Burkitt Lymphoma | 2 | 2022 | 328 | 0.820 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 222 | 0.760 |
Why?
|
Nanopores | 1 | 2021 | 50 | 0.750 |
Why?
|
Mutation | 31 | 2023 | 29717 | 0.750 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 341 | 0.730 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2021 | 491 | 0.720 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 20 | 0.720 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 6 | 2020 | 689 | 0.710 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 112 | 0.700 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 134 | 0.690 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 169 | 0.690 |
Why?
|
RNA Helicases | 1 | 2020 | 142 | 0.680 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 188 | 0.670 |
Why?
|
Janus Kinase 2 | 2 | 2021 | 527 | 0.660 |
Why?
|
Thrombocytosis | 1 | 2018 | 81 | 0.660 |
Why?
|
Back Pain | 2 | 2019 | 545 | 0.630 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2022 | 2948 | 0.610 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 206 | 0.600 |
Why?
|
Neoplasms | 11 | 2023 | 21596 | 0.600 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2019 | 177 | 0.590 |
Why?
|
Genes, abl | 2 | 2009 | 72 | 0.570 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2019 | 870 | 0.560 |
Why?
|
Lymphoma | 2 | 2022 | 1873 | 0.550 |
Why?
|
Specimen Handling | 1 | 2021 | 692 | 0.550 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 256 | 0.550 |
Why?
|
Myeloproliferative Disorders | 2 | 2020 | 603 | 0.550 |
Why?
|
Humans | 143 | 2024 | 742088 | 0.520 |
Why?
|
Stroke | 6 | 2023 | 9963 | 0.510 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.510 |
Why?
|
Hemorrhage | 5 | 2022 | 3461 | 0.500 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2018 | 433 | 0.500 |
Why?
|
Salivary Gland Neoplasms | 2 | 2022 | 297 | 0.500 |
Why?
|
DNA Helicases | 1 | 2020 | 861 | 0.490 |
Why?
|
Carcinoma, Lobular | 1 | 2018 | 484 | 0.480 |
Why?
|
Calcinosis | 4 | 2024 | 1497 | 0.450 |
Why?
|
Skin | 2 | 2019 | 4353 | 0.450 |
Why?
|
Karyotyping | 1 | 2015 | 1243 | 0.440 |
Why?
|
Medical Informatics | 1 | 2020 | 742 | 0.440 |
Why?
|
Sequence Analysis, DNA | 3 | 2021 | 4801 | 0.440 |
Why?
|
Sezary Syndrome | 1 | 2013 | 76 | 0.430 |
Why?
|
Translocation, Genetic | 6 | 2022 | 1417 | 0.430 |
Why?
|
Precancerous Conditions | 1 | 2019 | 971 | 0.420 |
Why?
|
Carcinoma, Ductal | 1 | 2012 | 101 | 0.420 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 930 | 0.400 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2012 | 299 | 0.390 |
Why?
|
Piperazines | 6 | 2020 | 2488 | 0.370 |
Why?
|
Aged | 51 | 2023 | 162944 | 0.360 |
Why?
|
Trypanocidal Agents | 2 | 2020 | 38 | 0.360 |
Why?
|
Anemia | 1 | 2019 | 1499 | 0.360 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2522 | 0.360 |
Why?
|
Pyrimidines | 7 | 2020 | 2933 | 0.350 |
Why?
|
Phosphoproteins | 1 | 2018 | 2440 | 0.350 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5169 | 0.340 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2015 | 1379 | 0.340 |
Why?
|
Laboratories | 2 | 2024 | 461 | 0.340 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2009 | 122 | 0.340 |
Why?
|
Lymph Nodes | 3 | 2017 | 3465 | 0.330 |
Why?
|
Sarcoma | 4 | 2021 | 1895 | 0.330 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 282 | 0.330 |
Why?
|
Thymus Neoplasms | 2 | 2023 | 268 | 0.330 |
Why?
|
Cytogenetic Analysis | 3 | 2021 | 295 | 0.330 |
Why?
|
Growth Inhibitors | 2 | 2020 | 385 | 0.330 |
Why?
|
Immunohistochemistry | 9 | 2022 | 11363 | 0.320 |
Why?
|
Male | 65 | 2023 | 349538 | 0.320 |
Why?
|
DNA Mutational Analysis | 4 | 2022 | 4187 | 0.320 |
Why?
|
Immunophenotyping | 4 | 2022 | 1866 | 0.320 |
Why?
|
Mosaicism | 2 | 2021 | 440 | 0.310 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 546 | 0.310 |
Why?
|
Neoplasms, Second Primary | 2 | 2014 | 1052 | 0.310 |
Why?
|
Chemokines, CC | 1 | 2009 | 291 | 0.310 |
Why?
|
Adenocarcinoma | 3 | 2022 | 6347 | 0.310 |
Why?
|
Lymphoma, T-Cell | 2 | 2021 | 299 | 0.300 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2021 | 93 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5163 | 0.300 |
Why?
|
Interferon Regulatory Factors | 1 | 2009 | 270 | 0.300 |
Why?
|
Hodgkin Disease | 1 | 2015 | 1413 | 0.290 |
Why?
|
Atherosclerosis | 5 | 2024 | 3428 | 0.290 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2022 | 670 | 0.290 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2022 | 1659 | 0.290 |
Why?
|
Gene Frequency | 3 | 2020 | 3587 | 0.290 |
Why?
|
Middle Aged | 51 | 2023 | 213127 | 0.290 |
Why?
|
Treponema pallidum | 2 | 2018 | 40 | 0.290 |
Why?
|
Breast Neoplasms | 4 | 2019 | 20774 | 0.290 |
Why?
|
Female | 66 | 2022 | 379592 | 0.280 |
Why?
|
Diagnosis, Differential | 8 | 2022 | 12958 | 0.280 |
Why?
|
Prognosis | 12 | 2023 | 29010 | 0.280 |
Why?
|
Genetic Testing | 4 | 2021 | 3439 | 0.280 |
Why?
|
Laboratory Proficiency Testing | 2 | 2024 | 19 | 0.280 |
Why?
|
Protein Kinase Inhibitors | 9 | 2022 | 5522 | 0.270 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2012 | 2938 | 0.260 |
Why?
|
Neoplasm, Residual | 2 | 2023 | 974 | 0.260 |
Why?
|
Young Adult | 23 | 2022 | 56350 | 0.260 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 651 | 0.260 |
Why?
|
Aged, 80 and over | 25 | 2021 | 57683 | 0.260 |
Why?
|
Interferon Type I | 1 | 2009 | 542 | 0.250 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2023 | 2455 | 0.250 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5662 | 0.250 |
Why?
|
Uric Acid | 2 | 2022 | 760 | 0.240 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13019 | 0.240 |
Why?
|
Purpura Fulminans | 1 | 2024 | 22 | 0.240 |
Why?
|
Syphilis | 2 | 2018 | 226 | 0.240 |
Why?
|
Gastrointestinal Tract | 2 | 2022 | 814 | 0.230 |
Why?
|
Oncogene Fusion | 2 | 2021 | 99 | 0.230 |
Why?
|
Adult | 43 | 2022 | 213712 | 0.230 |
Why?
|
Hyperemia | 2 | 2021 | 224 | 0.220 |
Why?
|
Methenamine | 1 | 2022 | 5 | 0.220 |
Why?
|
K562 Cells | 2 | 2018 | 632 | 0.220 |
Why?
|
Algorithms | 2 | 2020 | 13853 | 0.220 |
Why?
|
Bone Marrow Cells | 4 | 2023 | 2513 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1361 | 0.210 |
Why?
|
Retrospective Studies | 18 | 2023 | 77098 | 0.210 |
Why?
|
Fatal Outcome | 2 | 2019 | 1849 | 0.210 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2021 | 14 | 0.200 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5851 | 0.200 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 88 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13655 | 0.200 |
Why?
|
Xanthine Oxidase | 1 | 2021 | 64 | 0.200 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.200 |
Why?
|
Bone Cysts | 1 | 2021 | 47 | 0.190 |
Why?
|
STAT Transcription Factors | 1 | 2021 | 182 | 0.190 |
Why?
|
Receptor, trkA | 1 | 2022 | 164 | 0.190 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.190 |
Why?
|
Bile Duct Neoplasms | 2 | 2017 | 567 | 0.190 |
Why?
|
Cholangiocarcinoma | 2 | 2017 | 516 | 0.190 |
Why?
|
Endometrial Stromal Tumors | 1 | 2021 | 44 | 0.190 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2023 | 2028 | 0.190 |
Why?
|
Janus Kinases | 1 | 2021 | 244 | 0.190 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2017 | 569 | 0.190 |
Why?
|
Oncogenes | 2 | 2017 | 1263 | 0.190 |
Why?
|
Trypanosomiasis, African | 1 | 2020 | 28 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2021 | 1377 | 0.180 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2021 | 91 | 0.180 |
Why?
|
Leukoaraiosis | 1 | 2021 | 120 | 0.180 |
Why?
|
Trypanosoma brucei brucei | 1 | 2020 | 43 | 0.180 |
Why?
|
Ehrlichiosis | 1 | 2020 | 29 | 0.180 |
Why?
|
Carcinoma, Small Cell | 1 | 2022 | 420 | 0.180 |
Why?
|
Chromosomes, Human, Y | 1 | 2021 | 148 | 0.180 |
Why?
|
Blast Crisis | 1 | 2020 | 103 | 0.180 |
Why?
|
Anaplasma phagocytophilum | 1 | 2020 | 37 | 0.180 |
Why?
|
Pyridines | 5 | 2020 | 2818 | 0.180 |
Why?
|
Pathology, Molecular | 1 | 2023 | 325 | 0.180 |
Why?
|
Hematology | 1 | 2023 | 219 | 0.180 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5171 | 0.180 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 135 | 0.170 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1683 | 0.170 |
Why?
|
Uterine Neoplasms | 2 | 2020 | 1513 | 0.170 |
Why?
|
Trace Elements | 1 | 2021 | 198 | 0.170 |
Why?
|
Endometrial Neoplasms | 2 | 2021 | 1351 | 0.170 |
Why?
|
Signal Transduction | 5 | 2021 | 23387 | 0.170 |
Why?
|
Humerus | 1 | 2021 | 265 | 0.170 |
Why?
|
Alleles | 3 | 2022 | 6931 | 0.170 |
Why?
|
Prenatal Injuries | 1 | 2018 | 13 | 0.170 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 380 | 0.170 |
Why?
|
Adipocytes | 2 | 2020 | 1182 | 0.170 |
Why?
|
Biological Assay | 1 | 2022 | 652 | 0.160 |
Why?
|
Myofibroblasts | 1 | 2020 | 221 | 0.160 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 233 | 0.160 |
Why?
|
Bone Marrow Diseases | 1 | 2020 | 230 | 0.160 |
Why?
|
Fibula | 1 | 2021 | 269 | 0.160 |
Why?
|
Codon, Nonsense | 1 | 2019 | 281 | 0.160 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2022 | 325 | 0.160 |
Why?
|
Genotype | 5 | 2021 | 12946 | 0.160 |
Why?
|
Point Mutation | 1 | 2004 | 1624 | 0.160 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2020 | 253 | 0.160 |
Why?
|
Incubators, Infant | 1 | 2017 | 6 | 0.160 |
Why?
|
Peptidomimetics | 1 | 2018 | 34 | 0.160 |
Why?
|
Receptors, Steroid | 1 | 2018 | 155 | 0.160 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 249 | 0.160 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 44 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2012 | 890 | 0.160 |
Why?
|
Thymoma | 1 | 2019 | 186 | 0.160 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 25 | 0.160 |
Why?
|
Germ Cells | 1 | 2022 | 628 | 0.160 |
Why?
|
Trypanosoma cruzi | 1 | 2020 | 198 | 0.150 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.150 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2018 | 190 | 0.150 |
Why?
|
Antigens, CD19 | 1 | 2020 | 379 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9185 | 0.150 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2011 | 0.150 |
Why?
|
Adolescent | 16 | 2022 | 85649 | 0.150 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6454 | 0.150 |
Why?
|
Exanthema | 2 | 2019 | 488 | 0.150 |
Why?
|
Chordoma | 1 | 2020 | 359 | 0.150 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2020 | 326 | 0.150 |
Why?
|
Myofibroma | 1 | 2017 | 50 | 0.150 |
Why?
|
Cathepsins | 1 | 2018 | 239 | 0.150 |
Why?
|
Child | 11 | 2022 | 77478 | 0.150 |
Why?
|
Chromosome Aberrations | 3 | 2021 | 1811 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2018 | 578 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8425 | 0.140 |
Why?
|
Methamphetamine | 1 | 2018 | 152 | 0.140 |
Why?
|
Cardiomegaly | 1 | 2019 | 619 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 163 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.140 |
Why?
|
Classification | 1 | 2017 | 129 | 0.140 |
Why?
|
Leukemia | 2 | 2019 | 1507 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 10 | 2023 | 20086 | 0.140 |
Why?
|
Pelvic Pain | 1 | 2018 | 273 | 0.140 |
Why?
|
Cytogenetics | 1 | 2017 | 203 | 0.140 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 428 | 0.140 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 172 | 0.140 |
Why?
|
Trans-Activators | 3 | 2023 | 2924 | 0.140 |
Why?
|
Liver Failure | 1 | 2018 | 240 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2022 | 594 | 0.140 |
Why?
|
Neoplasm Staging | 5 | 2015 | 11001 | 0.140 |
Why?
|
Transcription Factors | 5 | 2023 | 12164 | 0.140 |
Why?
|
Carcinoma, Endometrioid | 1 | 2019 | 271 | 0.140 |
Why?
|
Femur | 2 | 2021 | 1297 | 0.140 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.140 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2017 | 233 | 0.130 |
Why?
|
Electromagnetic Fields | 1 | 2017 | 298 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 424 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 380 | 0.130 |
Why?
|
Benzamides | 5 | 2012 | 1378 | 0.130 |
Why?
|
Hematuria | 1 | 2017 | 235 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2017 | 348 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 202 | 0.130 |
Why?
|
World Health Organization | 2 | 2022 | 1317 | 0.130 |
Why?
|
Microcirculation | 1 | 2020 | 1285 | 0.130 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 747 | 0.130 |
Why?
|
Mouth | 1 | 2018 | 373 | 0.130 |
Why?
|
Cysteine Endopeptidases | 1 | 2018 | 563 | 0.130 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2019 | 484 | 0.130 |
Why?
|
Lymphatic Diseases | 2 | 2014 | 324 | 0.130 |
Why?
|
Streptococcus bovis | 1 | 2014 | 4 | 0.130 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3070 | 0.130 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 180 | 0.130 |
Why?
|
Strongyloides stercoralis | 1 | 2014 | 23 | 0.130 |
Why?
|
Strongyloidiasis | 1 | 2014 | 27 | 0.120 |
Why?
|
Superinfection | 1 | 2014 | 65 | 0.120 |
Why?
|
Fibrin | 1 | 2017 | 506 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2431 | 0.120 |
Why?
|
Transients and Migrants | 1 | 2016 | 155 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.120 |
Why?
|
Genomics | 4 | 2023 | 5692 | 0.120 |
Why?
|
Lymphadenitis | 1 | 2014 | 98 | 0.120 |
Why?
|
Helminthiasis, Animal | 1 | 2013 | 7 | 0.120 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2017 | 778 | 0.120 |
Why?
|
Anilides | 1 | 2017 | 404 | 0.120 |
Why?
|
Dermatitis, Exfoliative | 1 | 2013 | 28 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5425 | 0.120 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9639 | 0.120 |
Why?
|
Fish Diseases | 1 | 2013 | 38 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17400 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 505 | 0.110 |
Why?
|
Peptides | 2 | 2018 | 4392 | 0.110 |
Why?
|
Bone Marrow Transplantation | 2 | 2019 | 2763 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1265 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 35342 | 0.110 |
Why?
|
Workflow | 3 | 2023 | 846 | 0.110 |
Why?
|
Molecular Biology | 1 | 2017 | 595 | 0.110 |
Why?
|
Nitriles | 1 | 2018 | 952 | 0.110 |
Why?
|
Receptors, Notch | 1 | 2017 | 739 | 0.110 |
Why?
|
Pyrazoles | 2 | 2020 | 1970 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 740 | 0.110 |
Why?
|
Gene Amplification | 2 | 2018 | 1062 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2915 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1631 | 0.110 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 491 | 0.110 |
Why?
|
Child, Preschool | 7 | 2021 | 40955 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 2 | 2017 | 1337 | 0.110 |
Why?
|
Immunotherapy | 2 | 2022 | 4414 | 0.110 |
Why?
|
Meningitis, Bacterial | 1 | 2014 | 218 | 0.110 |
Why?
|
Machado-Joseph Disease | 1 | 2012 | 26 | 0.110 |
Why?
|
Flow Cytometry | 1 | 2023 | 5975 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1086 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1073 | 0.100 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1612 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1237 | 0.100 |
Why?
|
Medical Oncology | 2 | 2022 | 2235 | 0.100 |
Why?
|
Peritoneal Neoplasms | 1 | 2018 | 663 | 0.100 |
Why?
|
Vincristine | 2 | 2012 | 1036 | 0.100 |
Why?
|
Drug Discovery | 1 | 2020 | 1057 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1255 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2023 | 2643 | 0.100 |
Why?
|
Mesothelioma | 1 | 2018 | 818 | 0.100 |
Why?
|
Bone Marrow Examination | 2 | 2023 | 157 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1694 | 0.100 |
Why?
|
Endothelium, Vascular | 2 | 2022 | 4455 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 654 | 0.100 |
Why?
|
Antimalarials | 1 | 2018 | 903 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1596 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2020 | 1914 | 0.090 |
Why?
|
Sirolimus | 2 | 2018 | 1562 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2019 | 3020 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1585 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 220 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6756 | 0.090 |
Why?
|
Pruritus | 1 | 2013 | 359 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4553 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3770 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2014 | 637 | 0.090 |
Why?
|
Recurrence | 1 | 2022 | 8333 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 692 | 0.090 |
Why?
|
Sepsis | 1 | 2024 | 2589 | 0.090 |
Why?
|
Bone and Bones | 1 | 2020 | 2575 | 0.090 |
Why?
|
Incidence | 3 | 2023 | 20928 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 933 | 0.090 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 16665 | 0.090 |
Why?
|
Risk Assessment | 4 | 2024 | 23320 | 0.090 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3133 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2018 | 3444 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1184 | 0.090 |
Why?
|
Radiology | 1 | 2023 | 2090 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1554 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4839 | 0.080 |
Why?
|
Phenotype | 3 | 2021 | 16331 | 0.080 |
Why?
|
Stem Cell Transplantation | 2 | 2018 | 1618 | 0.080 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 182 | 0.080 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2011 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3278 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14720 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2021 | 193 | 0.080 |
Why?
|
Gene Duplication | 2 | 2022 | 330 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2842 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 623 | 0.080 |
Why?
|
Seizures | 1 | 2020 | 2851 | 0.080 |
Why?
|
Farnesyltranstransferase | 1 | 2007 | 76 | 0.080 |
Why?
|
Molecular Structure | 3 | 2020 | 1907 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11472 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2021 | 3258 | 0.070 |
Why?
|
Echocardiography | 1 | 2019 | 5097 | 0.070 |
Why?
|
Dermatitis, Atopic | 1 | 2013 | 653 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6440 | 0.070 |
Why?
|
Disease Progression | 2 | 2022 | 13256 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3456 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5249 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3691 | 0.070 |
Why?
|
Infant | 4 | 2020 | 35070 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2012 | 3701 | 0.070 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2006 | 146 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15108 | 0.070 |
Why?
|
Pilot Projects | 4 | 2024 | 8297 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2018 | 3119 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7317 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2107 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 40054 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3557 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4664 | 0.060 |
Why?
|
Glioma | 1 | 2019 | 3388 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5462 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2020 | 1372 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6891 | 0.060 |
Why?
|
src-Family Kinases | 1 | 2006 | 551 | 0.060 |
Why?
|
Receptors, Complement | 1 | 2024 | 264 | 0.060 |
Why?
|
Boston | 3 | 2021 | 9305 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2410 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4029 | 0.050 |
Why?
|
Thorax | 2 | 2020 | 547 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 72145 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4282 | 0.050 |
Why?
|
Human papillomavirus 18 | 1 | 2022 | 128 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8626 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2020 | 25575 | 0.050 |
Why?
|
Coronary Vessels | 2 | 2024 | 3099 | 0.050 |
Why?
|
Lung | 1 | 2019 | 9826 | 0.050 |
Why?
|
Mass Screening | 1 | 2016 | 5238 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4229 | 0.050 |
Why?
|
Ceramides | 1 | 2022 | 198 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2021 | 194 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 508 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2022 | 262 | 0.050 |
Why?
|
Lipids | 2 | 2022 | 3302 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12797 | 0.050 |
Why?
|
Isomerism | 1 | 2020 | 201 | 0.050 |
Why?
|
Mice | 8 | 2020 | 81045 | 0.050 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2020 | 83 | 0.050 |
Why?
|
Drug Resistance | 1 | 2006 | 1608 | 0.050 |
Why?
|
Epithelioid Cells | 1 | 2020 | 71 | 0.040 |
Why?
|
Phosphorus | 1 | 2021 | 338 | 0.040 |
Why?
|
Italy | 2 | 2016 | 828 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6382 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2009 | 2066 | 0.040 |
Why?
|
Hong Kong | 1 | 2019 | 148 | 0.040 |
Why?
|
Minnesota | 1 | 2020 | 343 | 0.040 |
Why?
|
Organizations, Nonprofit | 1 | 2020 | 104 | 0.040 |
Why?
|
Coronary Angiography | 2 | 2024 | 4567 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2723 | 0.040 |
Why?
|
Florida | 1 | 2020 | 435 | 0.040 |
Why?
|
Cell Survival | 2 | 2020 | 5872 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Metaplasia | 1 | 2019 | 313 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2021 | 391 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2022 | 591 | 0.040 |
Why?
|
Copper | 1 | 2021 | 366 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 200 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1727 | 0.040 |
Why?
|
Selenium | 1 | 2021 | 402 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12773 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 53187 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1095 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 94 | 0.040 |
Why?
|
Magnesium | 1 | 2021 | 813 | 0.040 |
Why?
|
Animals | 10 | 2020 | 168561 | 0.040 |
Why?
|
Tretinoin | 1 | 2020 | 516 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 214 | 0.040 |
Why?
|
Morpholines | 1 | 2020 | 561 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2017 | 141 | 0.040 |
Why?
|
Hyperbilirubinemia | 1 | 2017 | 77 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 276 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 683 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2017 | 318 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9410 | 0.040 |
Why?
|
Epistaxis | 1 | 2017 | 111 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2022 | 1118 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3800 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2022 | 1363 | 0.030 |
Why?
|
Intestinal Fistula | 1 | 2017 | 140 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1099 | 0.030 |
Why?
|
Tyrosine | 1 | 2020 | 1460 | 0.030 |
Why?
|
Angiopoietin-2 | 1 | 2017 | 170 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2022 | 1572 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1636 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15244 | 0.030 |
Why?
|
Pain Perception | 1 | 2017 | 190 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 688 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1720 | 0.030 |
Why?
|
Prednisone | 2 | 2014 | 1567 | 0.030 |
Why?
|
Bartonella Infections | 1 | 2014 | 22 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39004 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15494 | 0.030 |
Why?
|
Quinolines | 1 | 2020 | 719 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15056 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2017 | 252 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 62966 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 462 | 0.030 |
Why?
|
Chest Pain | 1 | 2022 | 1113 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1507 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1905 | 0.030 |
Why?
|
Plasma Cells | 1 | 2018 | 592 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2015 | 147 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 927 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2015 | 323 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9387 | 0.030 |
Why?
|
Photophobia | 1 | 2014 | 67 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 544 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 399 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1434 | 0.030 |
Why?
|
Antarctic Regions | 1 | 2013 | 17 | 0.030 |
Why?
|
Abdomen | 1 | 2020 | 1107 | 0.030 |
Why?
|
Life Cycle Stages | 1 | 2014 | 160 | 0.030 |
Why?
|
Vaginal Smears | 1 | 2016 | 511 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14554 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 659 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2015 | 462 | 0.030 |
Why?
|
Helminths | 1 | 2013 | 35 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1780 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2899 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15530 | 0.030 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 233 | 0.030 |
Why?
|
Iron | 1 | 2021 | 1773 | 0.030 |
Why?
|
Analgesia | 1 | 2017 | 459 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2384 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1085 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2895 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 892 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7716 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2747 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.030 |
Why?
|
Neutropenia | 1 | 2017 | 891 | 0.030 |
Why?
|
Nausea | 1 | 2014 | 665 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2417 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4771 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2019 | 11470 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3571 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9144 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1586 | 0.020 |
Why?
|
Fishes | 1 | 2013 | 569 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2723 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18006 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2857 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1483 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10248 | 0.020 |
Why?
|
Malaria, Falciparum | 1 | 2018 | 1071 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2450 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2968 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4465 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3582 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3164 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2014 | 847 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1477 | 0.020 |
Why?
|
Tail | 1 | 2009 | 97 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2009 | 136 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5062 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9679 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2187 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1274 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2009 | 259 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2012 | 880 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16678 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2012 | 701 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2041 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21821 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5753 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3611 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29087 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 898 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3127 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1119 | 0.020 |
Why?
|
Protein Prenylation | 1 | 2007 | 73 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1967 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
Software | 1 | 2021 | 4434 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3199 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7873 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1382 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1525 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
Headache | 1 | 2014 | 1219 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3937 | 0.020 |
Why?
|
Adipogenesis | 1 | 2009 | 358 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2016 | 1135 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4554 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 24913 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6540 | 0.020 |
Why?
|
Carcinoma | 1 | 2017 | 2374 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3502 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3328 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
Electroencephalography | 1 | 2020 | 6142 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3564 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4147 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2014 | 2107 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2597 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2906 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4200 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4328 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5304 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1983 | 0.020 |
Why?
|
Body Composition | 1 | 2013 | 2400 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1723 | 0.010 |
Why?
|
Stromal Cells | 1 | 2009 | 1353 | 0.010 |
Why?
|
Tibia | 1 | 2009 | 1075 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2009 | 840 | 0.010 |
Why?
|
Mutagenesis | 1 | 2007 | 1263 | 0.010 |
Why?
|
Bleomycin | 1 | 2004 | 499 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4231 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Etoposide | 1 | 2004 | 637 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2009 | 10472 | 0.010 |
Why?
|
Osteogenesis | 1 | 2009 | 1299 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13921 | 0.010 |
Why?
|
Spine | 1 | 2009 | 1143 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4823 | 0.010 |
Why?
|
Apoptosis | 2 | 2009 | 9715 | 0.010 |
Why?
|
United States | 2 | 2020 | 69693 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8621 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10163 | 0.010 |
Why?
|
RNA Interference | 1 | 2009 | 2890 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19862 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 2024 | 0.010 |
Why?
|
Pain | 1 | 2014 | 4961 | 0.010 |
Why?
|
Adiposity | 1 | 2009 | 1806 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2007 | 6313 | 0.010 |
Why?
|
Protein Conformation | 1 | 2007 | 4013 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21719 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3847 | 0.010 |
Why?
|
Piperidines | 1 | 2007 | 1602 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4438 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1769 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2236 | 0.010 |
Why?
|
Homeostasis | 1 | 2009 | 3335 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8829 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Doxorubicin | 1 | 2004 | 2215 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10578 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8455 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2009 | 3381 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12220 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5454 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6259 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15994 | 0.010 |
Why?
|
Brain | 1 | 2018 | 26343 | 0.010 |
Why?
|